• Rest EZ posted a net loss of $14,700 for fiscal 2026, widening from a loss of $7,900 a year earlier.
• Selling, general and administrative expense rose to $14,700 from $7,900.
• Sales were flat at no revenue, with cost of sales also unchanged at no cost of sales.
• Cash used in operating activities narrowed to $3,556 from $44,705, while financing cash flow was flat at no financing inflows.
• Operations remained centered on its Rest EZ Sleep Aid Supplement, with plans to expand distribution to more wholesalers and retail chains.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. REST EZ Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-094478), on August 28, 2026, and is solely responsible for the information contained therein.